Category: Pharmaceuticals - Page 2
PCSK9 Inhibitors vs Statins: Side Effects and Outcomes
Statins and PCSK9 inhibitors both lower LDL cholesterol but differ in effectiveness, side effects, and cost. Statins are first-line and affordable; PCSK9 inhibitors offer stronger LDL reduction without muscle pain but require injections and are expensive. Learn who benefits most from each.
learn more
Generic vs. Brand Name Drugs: What You Need to Know About Bioequivalence and Cost Savings
Generic drugs save billions annually and work just as well as brand-name versions for most people. Learn how bioequivalence works, when to be cautious, and why cost savings don’t mean lower quality.
learn more
Daptomycin Muscle Toxicity: Essential CK Monitoring and Symptoms Guide
Daptomycin treats serious infections but carries muscle toxicity risks. Learn how to monitor CK levels, recognize symptoms, and manage risks safely.
learn more
Serious vs Non-Serious Adverse Events: When to Report in Clinical Trials
Learn the critical difference between serious and non-serious adverse events in clinical trials, when each must be reported, and how misclassification wastes resources and risks patient safety.
learn more
Future Biosimilars: Upcoming Patent Expirations and Market Entry
Upcoming patent expirations for blockbuster biologics like Keytruda and Eylea are set to unleash a wave of biosimilars, potentially saving the U.S. healthcare system hundreds of billions. Here’s what’s coming, who’s entering the market, and how it will change patient access.
learn more
How to Read Contraindications and Warnings on Drug Labels: A Practical Guide
Learn how to read contraindications and warnings on drug labels to avoid dangerous reactions. Understand FDA-required sections, boxed warnings, and what to ask your pharmacist for safer medication use.
learn more
Quality Control Testing: Step-by-Step Process in Generic Manufacturing QA
Learn the six essential steps of quality control testing in generic manufacturing, from defining standards to taking corrective action. Discover how real-time data, trained teams, and proper tools reduce defects and save money.
learn more
Regulatory Exclusivity: How Non-Patent Protections Delay Generic Drugs
Regulatory exclusivity gives drug makers guaranteed market protection without patents, delaying generics for 5 to 12 years. It keeps prices high but drives innovation. Here's how it works - and why it's changing.
learn more
FDA Orange Book: Where to Find Patent Expiration Dates for Generic Drugs
Learn where to find accurate patent expiration dates in the FDA Orange Book to predict when generic drugs will become available. Includes step-by-step search tips, common pitfalls, and how to interpret patent and exclusivity data.
learn more
Pharmacy Reimbursement: How Generic Substitution Affects Pharmacies and Patients Financially
Generic substitution was meant to lower drug costs, but flawed reimbursement models now benefit PBMs more than patients or pharmacies. Learn how MAC lists, spread pricing, and dispensing fees shape who really saves money.
learn more